9
Total deals
$10.7B
Total value
$1.5B
Avg deal
$7.2B
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Chimerix
Chimerix is a biotechnology company developing therapeutics for antiviral diseas…
|
2025-03-05 | Acquisition | Complete | $935.0M | Deal → |
| 2 |
GW Pharmaceuticals
GW Pharmaceuticals is a biopharmaceutical company focused on discovering, develo…
|
2021-02-03 | Acquisition | Complete | $7.2B | Deal → |
| 3 |
Cavion
Cavion is a clinical stage pharmaceutical company committed to providing patient…
|
2019-08-13 | Acquisition | Complete | $321.5M | Deal → |
| 4 |
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to t…
|
2016-05-31 | Acquisition | Complete | $1.5B | Deal → |
| 5 |
Amolyt Pharma
Amolyt Pharma specializes in peptides for the treatment of rare endocrine and me…
|
2016-05-11 | Acquisition | Complete | $20.5M | Deal → |
| 6 |
Gentium
Gentium S.p.A. is public (GENT - NASDAQ) biopharmaceutical company specializing …
|
2013-12-19 | Acquisition | Complete | — | Deal → |
| 7 |
EUSA Pharma
EUSA Pharma is a pharmaceutical company developing and licensing late-stage onco…
|
2012-04-26 | Acquisition | Complete | $650.0M | Deal → |
| 8 |
Azur Pharma
Azur Pharma is a pharmaceutical company with commercial franchises in pain, psyc…
|
2011-09-19 | Merge | Complete | — | Deal → |
| 9 |
O
Orphan Medical
Orphan Medical is a Health Care company.
|
2005-04-19 | Acquisition | Complete | $122.6M | Deal → |